導(dǎo)師簡(jiǎn)介
姓名:劉志芬 性別:女 政治面貌:中共黨員
學(xué)歷:研究生 學(xué)位:博士 職稱:主任醫(yī)師
博、碩導(dǎo)師:博士研究生導(dǎo)師,博士后合作導(dǎo)師
山西省“三晉英才”支持計(jì)劃拔尖骨干人才;
山西省醫(yī)學(xué)科技創(chuàng)新人才強(qiáng)醫(yī)計(jì)劃醫(yī)學(xué)科技領(lǐng)軍人才;
山西省委組織部表?yè)P(yáng)的擔(dān)當(dāng)作為干部;
山西醫(yī)科大學(xué)精神衛(wèi)生學(xué)系主任;
山西醫(yī)科大學(xué)第一醫(yī)院精神衛(wèi)生科主任;
山西醫(yī)科大學(xué)第一臨床醫(yī)學(xué)院精神醫(yī)學(xué)教研室副主任(主持工作)。
專業(yè)特長(zhǎng):抑郁障礙、心身疾病的基礎(chǔ)與臨床研究
一.學(xué)習(xí)及工作經(jīng)歷
1.2005/09–2008/07山西醫(yī)科大學(xué),精神病與精神衛(wèi)生學(xué),碩士;
2.2012/09-2015/07山西醫(yī)科大學(xué),精神病與精神衛(wèi)生學(xué),博士;
3.2013/01-2014/01美國(guó)德克薩斯州大學(xué)圣安東尼奧醫(yī)學(xué)中心,行為醫(yī)學(xué),訪問學(xué)者;
4.2008/09-2010/06山西醫(yī)科大學(xué)第一醫(yī)院精神衛(wèi)生科,住院醫(yī)師;
5.2010/07-2018/04山西醫(yī)科大學(xué)第一醫(yī)院精神衛(wèi)生科,主治醫(yī)師;
6.2018/04 -2023/10山西醫(yī)科大學(xué)第一醫(yī)院精神衛(wèi)生科,副主任醫(yī)師;
7.2023/10至今山西醫(yī)科大學(xué)第一醫(yī)院精神衛(wèi)生科,主任醫(yī)師;
8.2019/12-2024/06山西醫(yī)科大學(xué),精神衛(wèi)生學(xué)系,副主任;
9.2020/10-2021/04山西醫(yī)科大學(xué)第一醫(yī)院精神衛(wèi)生科,科副主任;
10.2021/04-2023/11山西醫(yī)科大學(xué)第一醫(yī)院精神衛(wèi)生科,科副主任(主持工作);
11.2023/11至今山西醫(yī)科大學(xué)第一醫(yī)院精神衛(wèi)生科,科主任;
12.2024/07至今山西醫(yī)科大學(xué),精神衛(wèi)生學(xué)系,主任。
二.學(xué)術(shù)團(tuán)體任職情況
1.中華醫(yī)學(xué)會(huì)精神醫(yī)學(xué)分會(huì)兒童精神病學(xué)組委員;
2.中華醫(yī)學(xué)會(huì)精神醫(yī)學(xué)分會(huì)婦女精神醫(yī)學(xué)組委員;
3.中華醫(yī)學(xué)會(huì)精神醫(yī)學(xué)分會(huì)綜合醫(yī)院心理研究協(xié)作組委員;
4.中華醫(yī)學(xué)會(huì)精神醫(yī)學(xué)分會(huì)精神創(chuàng)傷研究協(xié)作組委員;
5.中華醫(yī)學(xué)會(huì)心身醫(yī)學(xué)分會(huì)心身重癥醫(yī)學(xué)協(xié)作組委員;
6.中國(guó)醫(yī)師協(xié)會(huì)精神科醫(yī)師分會(huì)精準(zhǔn)醫(yī)療委員會(huì)委員;
7.中國(guó)醫(yī)藥教育協(xié)會(huì)心理與精神健康教育委員會(huì)委員;
8.中國(guó)心理衛(wèi)生協(xié)會(huì)心理評(píng)估專業(yè)委員會(huì)委員;
9.中國(guó)心理衛(wèi)生協(xié)會(huì)危機(jī)干預(yù)委員會(huì)委員;
10.國(guó)際人際心理治療協(xié)會(huì)中國(guó)分會(huì)委員;
11.國(guó)家精神心理疾病臨床醫(yī)學(xué)研究中心協(xié)同研究網(wǎng)絡(luò)平臺(tái)精神衛(wèi)生與心理健康領(lǐng)域?qū)<遥?/p>
12.北方精神醫(yī)學(xué)論壇抑郁障礙專委會(huì)副主任委員;
13.山西省醫(yī)師協(xié)會(huì)精神科醫(yī)師分會(huì)委員會(huì)會(huì)長(zhǎng);
14.山西省醫(yī)學(xué)會(huì)行為醫(yī)學(xué)專業(yè)委員會(huì)主任委員;
15.山西省住院醫(yī)師規(guī)范化培訓(xùn)精神衛(wèi)生科專業(yè)指導(dǎo)委員會(huì)主任委員;
16.山西省醫(yī)師協(xié)會(huì)心身醫(yī)學(xué)專業(yè)委員會(huì)副主任委員;
17.山西省醫(yī)師協(xié)會(huì)健康傳播委員會(huì)副主任委員;
18.山西省心理衛(wèi)生協(xié)會(huì)精神分析專委會(huì)副主任委員;
19.山西省藥理學(xué)會(huì)藥物代謝組學(xué)專業(yè)委員會(huì)副主任委員;
20.干部保健委員會(huì)保健專家。
三.主持與參與項(xiàng)目情況
1.國(guó)家自然科學(xué)基金面上項(xiàng)目,82171534,深部TMS靶向調(diào)控獎(jiǎng)賞環(huán)路對(duì)青少年抑郁癥非自殺性自傷行為的作用,2022-01至2025-12,55萬(wàn)元(主持);
2.國(guó)家自然科學(xué)基金青年項(xiàng)目,81601193,反義lncRNA-gsk3βAs3調(diào)控GSK-3β影響抑郁的研究機(jī)制,2017-01至2019-12,17萬(wàn)元(主持);
3.國(guó)家科技創(chuàng)新2030重大項(xiàng)目,2021ZD0200701,抑郁癥的社區(qū)人群隊(duì)列研究,2022-10至2026-12,312.622萬(wàn)元(橫向課題,參與);
4.國(guó)家科技創(chuàng)新2030重大項(xiàng)目,2021ZD0200600,抑郁癥的前瞻性臨床隊(duì)列研究,2022-07至2026-07,14.7萬(wàn)元(橫向課題,參與);
5.中央引導(dǎo)地方科技發(fā)展資金項(xiàng)目,YDZJSX2022A063,神經(jīng)導(dǎo)航TMS治療青少年抑郁癥注意力受損的模式探索和臨床研究,2022-07至2025-06,40萬(wàn)元(主持);
6.山西省科技創(chuàng)新人才團(tuán)隊(duì),202204051001027,抑郁障礙精準(zhǔn)診療,2022-07至2025-07,50萬(wàn)元(帶頭人);
7.山西省高等學(xué)校一般性教育改革創(chuàng)新項(xiàng)目,積極心理學(xué)視角下,“五育融合”的項(xiàng)目化學(xué)習(xí)對(duì)精神醫(yī)學(xué)本科生的臨床勝任力培養(yǎng)模式研究,2023-05至2025-05,1萬(wàn)元(主持);
8.國(guó)家重點(diǎn)研發(fā)計(jì)劃重大慢性非傳染性疾病防控研究課題,2016YFC130690,抗精神病藥物個(gè)體化優(yōu)選治療方案的研究,2016-09至2020-12,10萬(wàn)元,(橫向課題,主持);
9.2019年山西省重點(diǎn)研發(fā)計(jì)劃項(xiàng)目(國(guó)際合作方面),201903D421059,基因大數(shù)據(jù)在精神障礙中的診斷與預(yù)測(cè),2019-12至2022-12,10萬(wàn)元(主持);
10.山西省留學(xué)人員項(xiàng)目,2015-100,神經(jīng)可塑相關(guān)lncRNAs的篩選及其在抑郁癥發(fā)生發(fā)展中的作用,2016-01至2018-12,4萬(wàn)元(主持);
11.山西省基礎(chǔ)研究項(xiàng)目青年科技研究基金,2015021204,長(zhǎng)鏈非編碼RNA調(diào)控GSK3β在抑郁癥發(fā)生發(fā)展中的作用,2015-01至2017-12,3萬(wàn)元(主持)。
四.獲獎(jiǎng)情況
1.2021年,山西省科技廳科學(xué)技術(shù)進(jìn)步二等獎(jiǎng)(排名1),精神疾病分段式臨床路徑的研發(fā)與應(yīng)用;
2.2022年,山西省科技廳科學(xué)技術(shù)進(jìn)步二等獎(jiǎng)(排名6),抑郁障礙遺傳病理機(jī)制研究及臨床應(yīng)用探討;
3.2011年,山西省科技廳科學(xué)技術(shù)進(jìn)步二等獎(jiǎng)(排名4),抑郁癥神經(jīng)營(yíng)養(yǎng)通路病例機(jī)制研究及臨床應(yīng)用探討;
4.2009年,山西省科技廳科學(xué)技術(shù)進(jìn)步一等獎(jiǎng)(排名10),抑郁障礙信息資源庫(kù)的開發(fā)、發(fā)病機(jī)理及臨床應(yīng)用研究。
五.代表性論文
1.LiuP#,LiuZ#, WangJ, WangJ, GaoM, ZhangY, YangC, ZhangA, LiG, LiX, LiuS, LiuL, SunN*, ZhangK*. Immunoregulatory role of the gut microbiota in inflammatory depression.Nature communications,2024,15(1), 3003.
2.Ren T, Wen Y,Ma L, Qiao D, Li G, Li H, Wang X,Liu Z*. Psychosocial factors affect the occurrence of nonsuicidal self-injury in adolescents with major depressive disorder through chain mediation.Eur Arch Psychiatry Clin Neurosci, 2024. (IF: 2023 3.5)
3.Wen Y1?, Li H1?, Huang Y, Qiao D, Ren T, Lei L, Li G, Yang C, Xu Y, Han M,Liu Z*. Dynamic network characteristics of adolescents with major depressive disorder: Attention network mediates the association between anhedonia and attentional deficit.Human Brain Mapping, 2023, 44: 5749-5769. (IF:2023 4.756)
4.Liang X, Qiao D, Ren T, Wen Y, Xu Y, Ma L, Li Q, Li G,Liu Z*. Neural association between cognitive function and anhedonia in adolescents with melancholic major depressive disorder: a fNIRS study.Journal of Affective Disorders,2023, 338: 305-311. (IF:2022 6.533)
5.Zhang A1?, Qiao D1?, Wang Y,Yang C, Wang Y, Sun N, Hu X,Liu Z*, Zhang K*.Distinguishing between bipolar depression and unipolar depression based on the reward circuit activities and clinical characteristics: A machine learning analysis.Journal of Affective Disorders,2023, 327:46-53. (IF:2022 6.533)
6.Ma H,Xu Y,Qiao D, Wen Y, Zhao T, Wang X, Liang T, Li X*,LiuZ*. Abnormal sleep features in adolescent MDD and its potential in diagnosis and prediction of early efficacy.Sleep Med, 2023, 106: 116-122.(IF:2022 4.842)
7.LiuH1?;WenY1?;LiangX;Xu Y;Qiao D;YangC;HanM;LiH;RenT;ZhangX;LiG*;LiuZ*.Prefrontal cortex neural activity predicts reduction of NSSI in adolescents with MDD:an ERP study,Frontiers in Neuroscience,2022, 972870.(IF:2022 5.152)
8.Yang C, Zhang Ku, Zhang A, Sun N,Liu Z*, Zhang Ke*.Co-expressio network modeling identifies specific Inflammation and neurological disease-related genes mRNA modules in mood disorder. Frontiers in genetics, 2022, 865015. (IF:2022 4.599)
9.Li Q, Zhao W, Liu S, Zhao Y, Pan W, Wang X,Liu Z*, Xu Y*.Partial resistance to citalopram in a Wistar-Kyoto rat model of depression: An evaluation using resting-state functional MRI and graph analysis.Journal of Psychiatric Research. 2022, 151:242-251.(IF:2022 5.250)
10.Yang C, Duan Y, Lei L, Liu P, Zhang A, Li G, Sun N, Wang Y,Liu Z*, Zhang K*.Altered Cingulum Functioning in Major Depressive Disorder Patient With Suicide Attempts: A Resting-State Functional Magnetic Resonance Imaging Study.Frontiers in Neuroscience,2022, 849158. (IF:2022 5.152)
11.Qiao D; Liu H; Zhang X; Lei L; Sun N; Yang C; Li G; Guo M; Zhang Y; Zhang K*;Liu Z*.Exploring the potential of thyroid hormones to predict clinical improvements in depressive patients: A machine learning analysis of the real-world based study.Journal of Affective Disorders, 2022, 299: 159-165. (IF:2022 6.533)
12.Lei L#;Liu Z#;Zhang y;Guo M;Liup;Hu X;Yang C; Zhang A;Sun N;Wang Y*; Zhang K*.EEG Microstates as markers of Major Depressive Disorder and predictors of response to SSRIs therapy.Progress in Neuro-psychopharmacology & Biological Psychiatry, 2022, 116: 110514. (IF:2022 5.067)
13.Liu Z; Qiao D; Xu Y; Zhao W; Yang Y; Wen D; Li X; Nie X; Dong Y; Tang S; Jiang Y; Wang Y; Zhao J; Xu Y*. The Efficacy of computerized Cognitive Behavior Therapy (cCBT) for Depressive and Anxiety Symptoms in Patients with COVID-19: Randomized Controlled Trial,Journal of Medical Internet Research, 2021, 23: e26883. (IF:2020 5.034)
14.WenY,ZhangX, XuY,QiaoD,GuoS,SunN,YangC, HanM,LiuZ*. Cognitive impairment in adolescent major depressive disorder with non-suicidal self-injury: Evidence based on multi-indicator ERPs,Frontiers inHumanNeuroscience,2021, 15: 637407. (IF: 2020 2.673)
15.Qiao D, Zhang A, Sun N, Yang C, Li J, Zhao T, Wang Y, Xu Y, Wen Y, Zhang K*,Liu Z*. Altered Static and Dynamic Functional Connectivity of Habenula Associated with Suicidal Ideation in First-Episode, Drug-Na?ve Patients with Major Depressive Disorder.Frontiers inPsychiatry, 2020, 11: 608197. (IF:2019 2.849)
16.Liu Z, Li X, Chen C, Sun N, Wang Y, Yang C, Xu Y, Zhang K*. Identification of antisense lncRNAs-GSK-3βas a regulator in Major Depressive Disorder,Epigenomics,2020,12(19):1725-1738.(IF: 2019 4.112)
17.Xu Y, Ma H, Zhao T, Wen D, Wen Y, Qiao D,Liu Z*. Association between Period 3 Gene Polymorphisms and Adverse Effects of Antidepressants for Major Depressive Disorder,Genetics Testing and Molecular Biomarkers, 2019,23(12):843-849.(IF:2019 1.121)
18.Ma H,Liu Z*, Xu Y, Hu X, Sun N, Li X, Zhang K*. The association study of CLOCK gene polymorphisms with antidepressant effect in Chinese with major depressive disorder.Personalized medicine,2019,16:115-122.(IF: 2018 1.414).
19.Xu Y#*,Liu Z#, Song X, Zhang K, Li X, Li J, Yan X, Li Y, Xie Z, Zhang H. Cerebralcare Granule(R) attenuates cognitive impairment in rats continuously overexpressing microRNA-30e.Molecular medicine reports,2015,12:8032-8040 (IF:2015 1.559)
20.Liu Z, Guo H, Cao X, Cheng C, Yang C, Xu C, Zhang A, Sun N, Li X, Zhang K*. A combined study of GSK3beta polymorphisms and brain network topological metrics in major depressive disorder.Psychiatry Research: Neuroimaging,2014,223:210-217.(IF: 2014 2.831)
21.Liu Z, Li X, Sun N, Xu Y, Meng Y, Yang C, Wang Y, Zhang K*. Microarray profiling and co-expression network analysis of circulating lncRNAs and mRNAs associated with major depressive disorder.PloS one,2014,9:e93388 (IF: 2014 3.534)
22.Liu Z, Xu C, Xu Y, Wang Y, Zhao B, Lu Y, Cao X, Du C, Zhang K*. Decreased regional homogeneity in insula and cerebellum: a resting-state fMRI study in patients with major depression and subjects at high risk for major depression.Psychiatry Research: Neuroimaging,2010,182:211-215 (IF: 2010 3.435)
23.喬丹,梁秀梅,溫宇嬌,徐一凡,李琪琪,李改智,楊春霞,劉志芬*.青少年抑郁癥患者情感癥狀轉(zhuǎn)歸與認(rèn)知功能及腦氧合血紅蛋白水平的相關(guān)性分析.中華精神科雜志, 2024, 57(1): 25-32.
24.劉志芬,喬丹,張愛霞,康麗君,徐一凡,張克讓*.經(jīng)歷童年虐待抑郁癥患者靜息態(tài)功能磁共振成像研究.中華精神科雜志,2019.10,5(52),320-324.
六.代表性著作
1.參編《青少年抑郁癥的人際心理治療》,浙江科學(xué)技術(shù)出版社,2024年7月;
2.參編應(yīng)用心理學(xué)研究生教材《臨床心理學(xué)》,東南大學(xué)出版社,2022年12月;
3.參編國(guó)家衛(wèi)健委“十三五”規(guī)劃教材《心理評(píng)估》,人民衛(wèi)生出版社,2018年8月;
4.主編專著《抑郁障礙規(guī)范化診療及臨床路徑》,科學(xué)出版社,2017年6月。